Neoadjuvant Tislelizumab and Afatinib Show Promise in Head and Neck Cancer
In a groundbreaking advancement for the treatment of locally advanced head and neck squamous cell carcinoma (HNSCC), a recent phase ...
Tag: EGFR tyrosine kinase inhibitors
Osimertinib Myotoxicity: FDA Data Reveals Risks
In the rapidly evolving landscape of cancer therapeutics, osimertinib has emerged as a cornerstone in the treatment of advanced non-small ...
Combining MET and EGFR Inhibitors Boosts NSCLC Treatment
In the relentless battle against non-small cell lung cancer (NSCLC), a new beacon of hope emerges through the strategic combination ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!